- Home
- CLDI vs SSKN Comparison
CLDI vs SSKN Comparison
Compare CLDI & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- SSKN
- Stock Information
- Founded
- CLDI 2014
- SSKN 1989
- Country
- CLDI United States
- SSKN United States
- Employees
- CLDI N/A
- SSKN N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- SSKN Medical/Dental Instruments
- Sector
- CLDI Health Care
- SSKN Health Care
- Exchange
- CLDI Nasdaq
- SSKN Nasdaq
- Market Cap
- CLDI 8.7M
- SSKN 8.9M
- IPO Year
- CLDI N/A
- SSKN 2005
- Fundamental
- Price
- CLDI $1.49
- SSKN $1.65
- Analyst Decision
- CLDI
- SSKN Strong Buy
- Analyst Count
- CLDI 0
- SSKN 1
- Target Price
- CLDI N/A
- SSKN $6.00
- AVG Volume (30 Days)
- CLDI 231.9K
- SSKN 1.6M
- Earning Date
- CLDI 11-07-2025
- SSKN 11-13-2025
- Dividend Yield
- CLDI N/A
- SSKN N/A
- EPS Growth
- CLDI N/A
- SSKN N/A
- EPS
- CLDI N/A
- SSKN N/A
- Revenue
- CLDI N/A
- SSKN $32,848,000.00
- Revenue This Year
- CLDI N/A
- SSKN N/A
- Revenue Next Year
- CLDI N/A
- SSKN $9.70
- P/E Ratio
- CLDI N/A
- SSKN N/A
- Revenue Growth
- CLDI N/A
- SSKN 0.36
- 52 Week Low
- CLDI $1.10
- SSKN $1.38
- 52 Week High
- CLDI $46.68
- SSKN $3.86
- Technical
- Relative Strength Index (RSI)
- CLDI 47.51
- SSKN 46.31
- Support Level
- CLDI $1.10
- SSKN $1.54
- Resistance Level
- CLDI $1.56
- SSKN $1.73
- Average True Range (ATR)
- CLDI 0.14
- SSKN 0.17
- MACD
- CLDI 0.01
- SSKN -0.00
- Stochastic Oscillator
- CLDI 69.49
- SSKN 18.67
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.